What is the recommended treatment for streptococcal pharyngitis, including antibiotic choice, dosing, and supportive care?

Treatment of Streptococcal Pharyngitis

Amoxicillin 50 mg/kg once daily (maximum 1000 mg) for 10 days is the definitive first-line treatment for streptococcal pharyngitis, offering superior adherence with once-daily dosing while maintaining equivalent efficacy to penicillin. 1

First-Line Antibiotic Therapy

Penicillin-based antibiotics remain the gold standard because no penicillin-resistant Group A Streptococcus has ever been documented. 1 The two primary options are:

• Amoxicillin 50 mg/kg once daily (max 1000 mg) for 10 days – preferred for its once-daily dosing advantage that improves adherence 1
• Alternative amoxicillin dosing: 25 mg/kg twice daily (max 500 mg per dose) for 10 days 1
• Penicillin V at standard dosing (typically 250 mg 2-3 times daily) for 10 days 1, 2
• Benzathine penicillin G as a single intramuscular injection when oral adherence is a concern 1

The 10-day duration is non-negotiable for maximal pharyngeal eradication and prevention of acute rheumatic fever. 1

Management of Penicillin-Allergic Patients

Non-Anaphylactic Allergy (e.g., rash)

First-generation cephalosporins are the preferred alternative:

• Cephalexin 20 mg/kg twice daily (max 500 mg/dose) for 10 days 1
• Cefadroxil 30 mg/kg once daily (max 1 g) for 10 days 1

Anaphylactic Allergy (avoid all beta-lactams)

Clindamycin is the preferred alternative due to minimal resistance:

• Clindamycin 7 mg/kg three times daily (max 300 mg/dose) for 10 days – only ~1% GAS resistance 1

Macrolides are second-line due to significant resistance concerns:

• Azithromycin 12 mg/kg once daily (max 500 mg) for 5 days 1
• Clarithromycin 7.5 mg/kg twice daily (max 250 mg/dose) for 10 days 1
• Critical caveat: Macrolide resistance ranges from 5-8% in most U.S. regions but can be significantly higher in some areas, leading to treatment failure 1, 2

Symptomatic Management

Acetaminophen or NSAIDs (e.g., ibuprofen) are recommended for moderate-to-severe throat pain or high fever. 1

Important restrictions:

• Aspirin must be avoided in children due to Reye syndrome risk 1
• Systemic corticosteroids are NOT recommended – the modest pain reduction (~5 hours) does not justify potential adverse effects 1, 2

Expected Clinical Course

Symptomatic improvement typically occurs within 24-48 hours after starting antibiotics. 1 Lack of improvement within this timeframe should prompt reassessment for treatment failure or alternative diagnoses. 1

Antibiotic treatment achieves multiple goals: prevents acute rheumatic fever, prevents suppurative complications (peritonsillar abscess, cervical lymphadenitis), reduces transmission, and hastens symptom resolution. 1

Follow-Up and Post-Treatment Testing

Routine post-treatment throat cultures or rapid antigen tests are unnecessary after completing the full antibiotic course. 1, 2 Test-of-cure is not indicated because asymptomatic carriage does not require treatment.

Asymptomatic household contacts do not require testing or empiric antibiotics. 1

Agents to Avoid

Never use these antibiotics for streptococcal pharyngitis:

• Tetracyclines, sulfonamides, and trimethoprim-sulfamethoxazole – do not eradicate GAS 1
• Ciprofloxacin and older fluoroquinolones – ineffective against GAS 1

Special Considerations for Children < 3 Years

Routine testing is NOT recommended for children younger than 3 years because acute rheumatic fever is rare and classic streptococcal pharyngitis is uncommon in this age group. 1 Testing should only be considered when specific risk factors exist, such as an older sibling with confirmed GAS infection. 1

Common Pitfalls

• Do not prescribe shorter courses (5-7 days) – while some research suggests equivalence 3, the IDSA guideline firmly recommends 10 days for penicillin/amoxicillin to ensure maximal eradication and rheumatic fever prevention 1
• Be aware of regional macrolide resistance patterns when prescribing azithromycin or clarithromycin, as elevated resistance can markedly reduce treatment success 1
• Do not empirically treat without diagnostic confirmation in low-risk patients, as only 10% of adults and 15-35% of children with pharyngitis have GAS infection 2, 4